RT Journal Article
SR Electronic
T1 1383 Preclinical characterization of D3L-002, a novel cancer immunotherapy bispecific antibody that elicits potent anti-tumor efficacy via co-blocking TIGIT and PVRIG
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1538
OP A1538
DO 10.1136/jitc-2023-SITC2023.1383
VO 11
IS Suppl 1
A1 Rui, Haopeng
A1 Yang, Baotian
A1 Yang, Xiaofeng
A1 Zheng, Zhiqiang
A1 Chen, Zhiqiang
A1 Lu, Jingtao
A1 Wu, Peggy
A1 Wang, Jia
A1 Chen, Janet
A1 Wang, Allison
A1 Chen, George
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1538.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.